Scott A. Armstrong, MD, PhD, has been named Chair of the Department of Pediatric Oncology at Dana-Farber Cancer Institute and the David G. Nathan Professor of Pediatrics at Dana-Farber Cancer Institute, Boston Children’s Hospital, and Harvard Medical School. He will also serve as Associate Chief of the Division of Hematology and Oncology at Boston Children’s Hospital.
Dr. Armstrong is currently serving as the Grayer Family Chair, the Director of the Center for Epigenetics Research, Vice Chair of Pediatrics, and a member of the Cancer Biology and Genetics Program at Memorial Sloan Kettering Cancer Center (MSKCC). He is also Professor of Pediatrics at Weill Cornell Medical College.
Scott A. Armstrong, MD, PhD
Dr. Armstrong’s group has made seminal discoveries into the relationship between normal hematopoietic stem cells and leukemia and has identified specific epigenetic mechanisms as therapeutic opportunities. This work has led to the development of several new classes of therapeutic agents that target epigenetic mechanisms, with many already being tested in clinical trials for both children and adults.
His work has been recognized with the Till and McCulloch Award from the International Society of Experimental Hematology; the Claire W. and Richard P. Morse Research Award from Dana-Farber; the Wilson S. Stone Award from MD Anderson Cancer Center; the Paul Marks Prize for Cancer Research from MSKCC; the E. Mead Johnson Award from the Society for Pediatric Research; and the Dameshek Prize from the American Society of Hematology. ■